other material
confidence high
sentiment negative
materiality 0.95
HYPERION DEFI, INC. (HYPD): Nasdaq/NYSE listing notice — Eyenovia receives Nasdaq delisting notice due to low stock price; plans to appeal
HYPERION DEFI, INC.
- Nasdaq determined to delist Eyenovia's common stock because closing bid price was $0.10 or less for 10 consecutive trading days as of December 11, 2024.
- The Bid Price Cure Period (until March 17, 2025) was rendered unavailable by the Low Priced Stocks Rule.
- Eyenovia intends to appeal the delisting determination by December 19, 2024; appeal will stay suspension pending a Hearings Panel decision.
- On December 12, 2024, filed preliminary proxy for a special meeting on January 21, 2025 to approve a reverse stock split to regain compliance.
- No assurance of favorable decision from Nasdaq or that reverse split will increase stock price.